AstraZeneca Faces Class Action Lawsuit in UK over ‘Unproven’ Link between Vaccine and Serious Injuries
In the UK, a class action lawsuit against AstraZeneca has been filed by over 50 alleged victims and their relatives. They claim that the vaccine, known as Vaxzevria, has caused serious injuries and even death in some cases. A court document from February revealed that the vaccine can cause thrombosis with thrombocytopenia syndrome (TTS) in very rare cases. However, AstraZeneca argues that TTS can also occur without the vaccine and that a causal link would need to be proven in each individual case.
Despite this, independent studies have shown that the vaccine may have saved over 6 million lives worldwide in its first year of use. At least 81 deaths in the UK are suspected to be linked to TTS and hundreds of serious injuries. In Belgium, two deaths related to TTS after receiving COVID-19 vaccinations were reported in January 2022.
AstraZeneca stated that the withdrawal of the vaccine is a commercial decision due to it being outdated and newer alternatives being available to combat different variants of the virus. The company had previously updated the product information in April 2021 to include the potential for the vaccine to trigger TTS in very rare cases.
AstraZeneca maintains that the benefits of the vaccine outweigh the risks of rare side effects, as affirmed by regulators worldwide. The company stated that both clinical trials and real-world data demonstrate the vaccine’s acceptable safety profile. Ultimately,
